EUVIMEDEUVIMED entdecken
Crossref

Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy

Manju L Subramanian, Konstantina Sampani, Steven Ness, Fatima Tuz-Zahra, Sreevardhan Alluri, Xuejing Chen, Nicole H Siegel, Nurgul Aytan, Weiming Xia, Yorghos Tripodis, Michael L Alosco, Thor D Stein iD

Journal of Alzheimer’s Disease · 2025

DOI: 10.1177/13872877251378759 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2025. Verfasst von Manju L Subramanian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Vision Sciences, Boston, MA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Diabetic Retinopathy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: U.S. Department of Veterans Affairs, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetes has been linked to increased prevalence of dementia, but the link between diabetic retinopathy (DR) and Alzheimer's disease (AD) remains unclear.

Objective

This study aimed to evaluate potential associations between DR and AD-related protein biomarkers in plasma and ocular fluid.

Methods

A prospective, cross-sectional study collected human blood, vitreous, aqueous, and tear samples and measured amyloid-β (Aβ 40 , Aβ 42 ), total-tau (t-tau), phosphorylated-tau (ptau181), glial fibrillary acidic protein (GFAP), and neurofilament light chain (NfL) by digital immunoassays.

Results

The study included 79 eyes (79 patients) [41 females (59.4%); mean (SD) age 57.1 (12.2) years] of which DR was present in 44 (55.7%). All six biomarkers were significantly higher in plasma in participants with DR compared to those without DR [Aβ 40 p = 0.002, Aβ 42 p = 0.002, t-tau = 0.013, ptau181 p = 0.005, GFAP p = 0.010, and NfL p < 0.001]. Within vitreous, DR participants had significantly elevated t-tau (p = 0.002), ptau181 (p = 0.049), and NfL (p = 0.006); and within aqueous, higher NfL (p = < 0.001). Neuropsychological testing scores were lower in participants with DR than those without but did not reach statistical significance (Montreal-Cognitive-Assessment: p = 0.070; Mini-Mental-State-Exam: p = 0.057).

Conclusions

This study showed significant increases of AD associated protein biomarkers in plasma, vitreous, and aqueous in patients with DR. These results support a potential biological link between DR and AD pathology and suggest that DR, which tends to occur in younger individuals, may be a predictive factor for AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDiabetic RetinopathyHumansFemaleMaleBiomarkersCross-Sectional StudiesMiddle AgedAmyloid beta-PeptidesAgedtau ProteinsProspective StudiesNeurofilament ProteinsGlial Fibrillary Acidic ProteinUp-RegulationVitreous BodyTearsPeptide Fragments

Stichwörter der Autor:innen

Alzheimer’s diseaseamyloid-βdiabetes mellitusdiabetic retinopathyglial fibrillary acidic proteinneurofilament light chainptau181t-tau

Substanzen

BiomarkersAmyloid beta-Peptidestau ProteinsNeurofilament ProteinsGlial Fibrillary Acidic Proteinneurofilament protein LPeptide Fragments

Autor:innen und Institutionen

  • Department of Ophthalmology and Vision Sciences, Boston, MA, USA.
  • Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA.
  • Beetham Eye Institute, Joslin Diabetes Center, Boston, MA, USA.
  • Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  • Boston University Alzheimer's Disease Research Center and CTE Center, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.

ORCID-Profile: Thor D Stein

Förderung

  • U.S. Department of Veterans Affairs
  • National Institute on Aging

Zitieren

APA

Subramanian, M. L., Sampani, K., Ness, S., Tuz-Zahra, F., Alluri, S., Chen, X., Siegel, N. H., Aytan, N., Xia, W., Tripodis, Y., Alosco, M. L., & Stein, T. D. (2025). Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy. Journal of Alzheimer’s Disease. https://doi.org/10.1177/13872877251378759

Vancouver

Subramanian ML, Sampani K, Ness S, Tuz-Zahra F, Alluri S, Chen X, et al. Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy. Journal of Alzheimer’s Disease. 2025. doi:10.1177/13872877251378759

BibTeX
@article{Subramanian2025,
  author = {Subramanian, Manju L and Sampani, Konstantina and Ness, Steven and Tuz-Zahra, Fatima and Alluri, Sreevardhan and Chen, Xuejing and Siegel, Nicole H and Aytan, Nurgul and Xia, Weiming and Tripodis, Yorghos and Alosco, Michael L and Stein, Thor D},
  title = {Biomarkers for Alzheimer's disease are upregulated in patients with diabetic retinopathy},
  journal = {Journal of Alzheimer’s Disease},
  year = {2025},
  doi = {10.1177/13872877251378759}
}
Kostenlos starten →